NZ700644A - Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof - Google Patents
Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereofInfo
- Publication number
- NZ700644A NZ700644A NZ700644A NZ70064414A NZ700644A NZ 700644 A NZ700644 A NZ 700644A NZ 700644 A NZ700644 A NZ 700644A NZ 70064414 A NZ70064414 A NZ 70064414A NZ 700644 A NZ700644 A NZ 700644A
- Authority
- NZ
- New Zealand
- Prior art keywords
- derivatives
- application
- thiochromeno
- quinolin
- novel
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ700644A NZ700644A (en) | 2014-10-02 | 2014-10-02 | Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ700644A NZ700644A (en) | 2014-10-02 | 2014-10-02 | Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ700644A true NZ700644A (en) | 2015-11-27 |
Family
ID=55405612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ700644A NZ700644A (en) | 2014-10-02 | 2014-10-02 | Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ700644A (en) |
-
2014
- 2014-10-02 NZ NZ700644A patent/NZ700644A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2014241199A8 (en) | Compositions and methods for enhancing plant growth | |
AU2015237050A8 (en) | Quinoline derivatives as SMO inhibitors | |
GEP20207160B (en) | New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
WO2018067512A8 (en) | Spirocyclic compounds | |
NZ731789A (en) | Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof | |
EP3800248A3 (en) | Crispr-cas-related methods, compositions and components for cancer immunotherapy | |
WO2016044189A8 (en) | Methods of treating cancer using pd-1 axis binding antagonists and il-17 binding antagonists | |
EP3473624A4 (en) | Novel imidazopyridine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating cancer | |
MX2016002544A (en) | Compounds useful as immunomodulators. | |
PH12017500358A1 (en) | Cytotoxic benzodiazepine derivatives | |
MX2019010514A (en) | Compositions and methods for improving tomato production. | |
GEP20186933B (en) | Substituted dihydroisoquinoline compounds | |
EP3342858A4 (en) | Ror1-positive mesenchymal stem cells and method for preparing same, pharmaceutical composition containing ror1-positive mesenchymal stem cells and method for preparing same, and method for preventing or treating diseases by using ror1-positive mesenchymal stem cells | |
MX2017004618A (en) | Heparan sulfate biosynthesis inhibitors for the treatment of diseases. | |
EP3325608A4 (en) | Methods and microorganisms for the production of 1,3-butanediol | |
MX2016009663A (en) | Icariin derivatives. | |
WO2015123449A3 (en) | Compositions and methods of using microrna inhibitors | |
MX2016014436A (en) | Heterocyclyl-butanamide derivatives. | |
AU2018253600A1 (en) | Dosage forms and therapeutic uses of l-4-chlorokynurenine | |
EP3539951A4 (en) | Novel pyrimidine compound, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating cancer and inflammatory diseases | |
MX2020000135A (en) | New quinolinone compounds. | |
EP3638218A4 (en) | Compositions and methods targeting complement component 3 for inhibiting tumor growth | |
EP3694331A4 (en) | Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof | |
UA117318C2 (en) | 7-(morpholinyl)-2-(n-piperazinyl) methyl thieno[2, 3-c]pyridine derivatives as anticancer drugs | |
MX2018004474A (en) | Anti-cd43 antibody and use thereof for cancer treatment. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: NATIONAL DEFENSE MEDICAL CENTER, TW Effective date: 20150806 |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 OCT 2019 BY NORTH AMERICA INTELLECTUAL PROPERTY CORP. Effective date: 20180903 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 OCT 2020 BY NORTH AMERICA INTELLECTUAL PROPERTY CORP. Effective date: 20190903 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 OCT 2021 BY NORTH AMERICA INTELLECTUAL PROPERTY CORP. Effective date: 20200909 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 OCT 2022 BY A.P.T. PATENT AND TRADE MARK ATTORNEYS Effective date: 20220321 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 OCT 2023 BY A.P.T. PATENT AND TRADE MARK ATTORNEYS Effective date: 20230329 |